Natural resistance to malaria linked to variation in human red blood cell receptors

Natural resistance to malaria linked to variation in human red blood cell receptors
Researchers have discovered that protection from the most severe form of it is linked to natural variation in human red blood cell genes. A study from the Wellcome Trust Sanger Institute, the Wellcome Trust Centre for Human Genetics and their collaborators have identified a genetic rearrangement of red blood cell glycophorin receptors that confers a 40 percent reduced risk from severe malaria.
Published in Science, this is the first study to show that large structural variants in human glycophorin genes, which are unusually common in Africa, are protective against malarial disease. It opens a new avenue for research on vaccines to prevent malaria parasites invading red blood cells.
More than 200 million people a year are infected with malaria and the disease caused the deaths of nearly half a million people worldwide in 2015. Transmitted by mosquitos, the most widespread malaria parasite in Africa is Plasmodium falciparum; it is also the most dangerous.
Plasmodium parasites infect human red blood cells and gain entry via receptors on the cell surface. Previous studies on natural resistance to malaria had implicated a section of human genome near to a cluster of receptor genes. These receptors - glycophorins - are located on the surface of red blood cells and are amongst many receptors that bind Plasmodium falciparum. However, it is only now that they have been shown to be involved in protection against malaria.
Researchers investigated the glycophorin area of the genome in more detail than before using new whole-genome sequence data from 765 volunteers in the Gambia, Burkina Faso, Cameroon, and Tanzania. Using this new information they then undertook a study across the Gambia, Kenya, and Malawi that included 5310 individuals from the normal population and 4579 people who were hospitalised from severe malaria. They discovered that people who have a particular rearrangement of the glycophorin genes had a 40 percent reduced risk of severe malaria.
Dr Ellen Leffler from the University of Oxford, first author on the paper, said: "In this new study we found strong evidence that variation in the glycophorin gene cluster influences malaria susceptibility. We found some people have a complex rearrangement of GYPA and GYPB genes, forming a hybrid glycophorin, and these people are less likely to develop severe complications of the disease."
The hybrid GYPB-A gene is found in a particular rare blood group - part of the MNS blood group system - where it is known as Dante. The study found that the GYPB-A Dantu hybrid was present in some people from East Africa, in Kenya, Tanzania, and Malawi, but that it was not present in volunteers from West African populations.
Dr Kirk Rockett from the University of Oxford said: "Analysing the DNA sequences allowed us to identify the location of the join between glycophorins A and B in the hybrid gene. It showed us that the sequence is characteristic of the Dantu antigen in the MNS blood group system."
Studying the glycophorin gene cluster to determine differences between the sequences of the three genes with confidence is extremely challenging. This study gives insights into unpicking the region and how it connects to the MNS blood group system and impacts malaria susceptibility.
Professor Dominic Kwiatkowski, a lead author from the Wellcome Trust Sanger Institute and the University of Oxford, said: "We are starting to find that the glycophorin region of the genome has an important role in protecting people against malaria. Our discovery that a specific variant of glycophorin invasion receptors can give substantial protection against severe malaria will hopefully inspire further research on exactly how Plasmodium falciparum invade red blood cells. This could also help us discover novel parasite weaknesses that could be exploited in future interventions against this deadly disease."
The MNS system is a human blood group system based on two genes - glycophorin A and glycophorin B - on chromosome 4. There are 46 antigens in the system; the most common are called M, N, S, s and U.


Comments

Post a Comment

Popular posts from this blog

Breast cancer charities: How to make an impact

Breast cancer charities: How to make an impact With thousands of charities competing for donations, it can be difficult to know where a financial gift to a good cause will make the biggest impact. This article outlines the top  breast cancer  charities in the United States and their specific contributions to the cause, plus other factors to keep in mind before donating. The history of the pink ribbon The pink ribbon is a symbol of breast cancer and is often sold to raise money for breast cancer charities. Breast cancer activist and survivor Charlotte Hayley inspired the design of the pink ribbon, which is still in use today. Hayley initially handed out peach-coloured looped ribbons that she made herself with a card stating: "The National Cancer Institute's annual budget is $1.8 billion, only 5 percent goes for  cancer  prevention. Help us wake up our legislators and America by wearing this ribbon." In 1991, the Susan G. Komen Breast Cancer Foundati...
Read more

Lung cancer and cough: What is the connection?

Image
Lung cancer and cough: What is the connection? Everyone has experienced a nagging cough after a cold or needed to cough while in a quiet room. Despite these problems, coughing actually serves a very valuable and useful purpose. Coughing is a protective action, helping the lungs clear out potential germs or harmful objects.  Sometimes, however, that cough is not linked to a cold or infection and can linger for weeks to months at a time. This may lead people to wonder or worry that their cough is a sign of something more serious, such as  lung cancer . This article takes a look at the connection between coughing and lung cancer, including when someone should see a doctor. Coughing and lung cancer A cough associated with lung cancer may be either dry or wet. Not every a cough signifies the presence of lung cancer. However, many people do complain of a chronic cough or a "cough that just won't go away" at the time of their diagnosis. If a cough is associate...
Read more

For people with Type 2 diabetes, there is an additional incentive for keeping the disease under management

For people with Type 2 diabetes, there is an additional incentive for keeping the disease under management  Research shows a possible link between diabetes and cognitive decline, including increased risk for Alzheimer’s disease and vascular dementia. The scientific reason behind the link between diabetes and brain health is complex. Some scientists believe people with diabetes may also have insulin resistance or insulin deficiency that could damage brain cells enough to cause memory loss. Studies are underway to understand why 80 percent of people with Alzheimer’s disease also have some form of diabetes or disturbed glucose metabolism. However, so far, longitudinal research has not produced a consensus view regarding the link between blood glucose levels and cognitive impairment. Meanwhile, in South Florida, medical professionals are working with diabetic patients to minimize the risk of cognitive decline through a variety of methods that include lifestyle, medical and mental-...
Read more